Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurochem ; 100(3): 628-38, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17263792

ABSTRACT

Multipotent neural stem cells (NSCs) are competent for commitment to the oligodendrocyte (OL) lineage both in vitro and in vivo. We exploited this property to develop a rat neurospheres (NS)/oligospheres (OS)-based culture system to generate large numbers of highly enriched late OL progenitors (preOLs) and mature OLs (MatOLs). CNS neuroblastoma cell line B104-derived conditioned medium promoted the generation of nearly pure populations of preOLs from dissociated OS. The subsequent culture of preOLs with ciliary neurotrophic factor (CNTF) and 3,3',5'-triiodo-L-thyronine (T(3)) generated nearly pure populations of MatOLs. OL lineage specificity was confirmed by immunocytochemistry, quantitative RT-PCR and gene expression profiling, which demonstrated large differences between preOLs and MatOLs. The insulin-like growth factors (IGFs) are potent neuro-protective agents required for OL survival. We used this system to systematically define maturation-dependent changes in IGF signaling during the course of OL differentiation. The IGF-I and insulin receptors, insulin receptor substrate-1 (IRS-1) and IRS-2, protein kinase B (PKB)/Akt and Janus kinase (JNK) were expressed at higher levels in NS and preOLs compared with OS and MatOLs. Erk expression increased markedly from NS to OS, decreased only partially upon commitment to preOLs, and, in MatOLs, returned to a low level similar to NS. IGF activation of the generally proliferative Erk pathway was gradually acquired during NSC differentiation, whereas IGF activation of the generally pro-survival, anti-apoptotic PI3K/PKB pathway was consistently robust at each developmental stage.


Subject(s)
Brain Tissue Transplantation/methods , Cell Differentiation/physiology , Multipotent Stem Cells/metabolism , Oligodendroglia/metabolism , Somatomedins/metabolism , Stem Cells/metabolism , Animals , Animals, Newborn , Cell Culture Techniques/methods , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Lineage/drug effects , Cell Lineage/physiology , Cell Proliferation/drug effects , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , Ciliary Neurotrophic Factor/metabolism , Ciliary Neurotrophic Factor/pharmacology , Culture Media, Conditioned/pharmacology , Extracellular Signal-Regulated MAP Kinases/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , Insulin Receptor Substrate Proteins , Insulin-Like Growth Factor I/drug effects , Insulin-Like Growth Factor I/metabolism , Janus Kinase 1/drug effects , Janus Kinase 1/metabolism , Multipotent Stem Cells/drug effects , Oligodendroglia/drug effects , Phosphoproteins/drug effects , Phosphoproteins/metabolism , Proto-Oncogene Proteins c-akt/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Rats , Signal Transduction/drug effects , Signal Transduction/physiology , Somatomedins/pharmacology , Stem Cells/drug effects , Triiodothyronine/metabolism , Triiodothyronine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...